How many insider trades does FilingIQ track for MDGL?

FilingIQ tracks 953 Form 4 insider transactions for MDGL (MADRIGAL PHARMACEUTICALS, INC.), covering filings from Jul 22, 2016 onwards. 37 of those are dated within the last 90 days.

Are MDGL insiders net buyers or net sellers?

Across the full Form 4 history for MDGL, 217 transactions (23%) were open-market purchases and 545 (57%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MDGL insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is MDGL in?

MADRIGAL PHARMACEUTICALS, INC. (MDGL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $10.15B.

MDGL insider trading

NasdaqGS Healthcare

MADRIGAL PHARMACEUTICALS, INC.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

953

Last 90 days

Buys / sells

23% / 57%

Market cap

$10.15B

About MADRIGAL PHARMACEUTICALS, INC.

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

Company website: www.madrigalpharma.com

MDGL insider activity at a glance

FilingIQ tracks 953 insider transactions for MDGL in filings since Jul 22, 2016. The most recent transaction is dated Sep 11, 2026.

Across the full history, 217 open-market purchases and 545 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MDGL insider trades is 58.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MDGL trades on FilingIQ Raw filings on SEC EDGAR

Latest MDGL Form 4 filings

Sibold William John President and CEO

S Sep 11, 2026

Kelley Shannon T General Counsel

S Aug 20, 2026

REED JOHN C

A Aug 18, 2026

Sibold William John President and CEO

BAKER BROS. ADVISORS LP

A Jun 18, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

13F funds holding MDGL

BAKER BROS. ADVISORS LP

$1.15B · 5.8% of AUM

Frequently asked

How many insider trades does FilingIQ track for MDGL?: FilingIQ tracks 953 Form 4 insider transactions for MDGL (MADRIGAL PHARMACEUTICALS, INC.), covering filings from Jul 22, 2016 onwards. 37 of those are dated within the last 90 days.
Are MDGL insiders net buyers or net sellers?: Across the full Form 4 history for MDGL, 217 transactions (23%) were open-market purchases and 545 (57%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MDGL insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is MDGL in?: MADRIGAL PHARMACEUTICALS, INC. (MDGL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $10.15B.

Methodology & sources

Every MDGL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.